A 32-year-old woman with pre-existing type 2 diabetes mellitus becomes pregnant. She was previously on metformin 1000 mg twice daily and glibenclamide 10 mg daily. At 8 weeks of gestation, she presents for antenatal booking. What is the recommended first-line antidiabetic agent for her pregnancy?

## Antidiabetic Management in Pre-Existing Diabetes in Pregnancy **Key Point:** In pre-existing diabetes (type 1 or type 2) during pregnancy, insulin is the gold standard. Metformin may be continued, but all oral hypoglycaemic agents (except metformin) must be discontinued and replaced with insulin. ### Rationale for Insulin in Pre-Existing Diabetes 1. **Placental Transfer Concerns** - Insulin does not cross the placenta → no fetal hyperinsulinemia - Glibenclamide crosses the placenta → fetal beta-cell stimulation → neonatal hypoglycaemia - Pioglitazone: inadequate pregnancy safety data 2. **Glycaemic Control Requirements** - Pre-existing diabetes requires tighter control than GDM alone - Insulin allows precise titration to achieve target HbA1c <6.5% in first trimester - Insulin sensitivity decreases with advancing gestation → frequent dose adjustments needed ### Drug-by-Drug Recommendations | Agent | Pre-Existing DM | Recommendation | |-------|-----------------|----------------| | **Insulin** | Type 1 or Type 2 | **Mandatory; first-line** | | **Metformin** | Type 2 | **May continue** (emerging safety data) | | **Glibenclamide** | Type 2 | **STOP; switch to insulin** | | **Other sulfonylureas** | Type 2 | **STOP; switch to insulin** | | **Pioglitazone** | Type 2 | **STOP; contraindicated** | | **DPP-4 inhibitors** | Type 2 | **Avoid; limited data** | | **GLP-1 agonists** | Type 2 | **Avoid; limited data** | **Clinical Pearl:** Metformin is increasingly accepted in pregnancy (especially in type 2 diabetes) because it does not cause fetal hyperinsulinemia. However, insulin remains the gold standard and is mandatory for type 1 diabetes and for type 2 diabetes when tighter control is needed. **High-Yield:** The key principle is: **Insulin + metformin (if tolerated) is the preferred regimen for pre-existing type 2 diabetes in pregnancy.** All other oral agents are discontinued. ### Insulin Regimen in Pre-Existing Diabetes 1. **Basal-bolus approach** (most common) - NPH insulin for basal coverage (morning and evening) - Rapid-acting insulin (aspart, lispro) before meals 2. **Insulin analogues** - Aspart, lispro, glulisine (rapid-acting) — safe in pregnancy - Detemir, glargine (long-acting) — increasingly used; safe data 3. **Monitoring** - Fasting and pre-meal blood glucose targets: 70–100 mg/dL - 2-hour postprandial target: <120 mg/dL - HbA1c target: <6.5% (if safe to achieve) **Warning:** Aggressive insulin therapy in early pregnancy increases hypoglycaemia risk. Dose reduction of 15–20% is often needed in first trimester due to improved insulin sensitivity. ## Why Option 0 Is Correct - **Metformin continuation** is acceptable (emerging evidence of safety; does not cross placenta significantly) - **Glibenclamide discontinuation** is mandatory (crosses placenta; causes fetal hyperinsulinemia) - **Insulin initiation** is required (gold standard for pre-existing diabetes in pregnancy) [cite:ACOG Practice Bulletin 190; ADA Standards of Care in Diabetes 2023]